Pulse Biosciences, Inc. (NASDAQ: PLSE) announced the appointment of Jon Skinner as the company’s Chief Financial Officer (CFO), effective February 3, 2025. Alongside his role as CFO, Mr. Skinner will ...

Pulse Biosciences, Inc.’s PLSE share price has dipped by 11.28%, which has investors questioning if this is right time to buy ...

The polling for the Delhi Assembly concluded on Wednesday evening, with a 58 per cent voter turnout, subject to revision, ...

Pulse, which named a new CEO last month, is pitching its pulsed field ablation technology as a way to shorten procedure times ...

In connection with his appointment, Pulse Biosciences granted Skinner options to purchase 300,000 shares of the company’s ...

Citi analyst Pat Cunningham adjusted the price target for Axalta Coating Systems (NYSE:AXTA), increasing it to $42.00, up from the previous $40.00, while keeping a Neutral rating on the stock.

Pulse Biosciences (Nasaq:PLSE) announced today that it appointed Jon Skinner as CFO, effective Feb. 3, 2025.

MIAMI - Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company focusing on its proprietary CellFX nanosecond Pulsed Field Ablation (nsPFA) technology, has announced the ...

Pulse Biosciences, Inc. (PLSE), a novel bioelectric medicine company, Tuesday announced the appointment of Jon Skinner as Chief ...

Pulse Biosciences has hired Jon Skinner as the bioelectric medicine company's new chief financial officer. Pulse on Tuesday said Skinner most recently served as vice president of financial planning ...

Pulse Biosciences (PLSE) announced the appointment of Jon Skinner as Chief Financial Officer, effective February 3. “I am excited to announce ...

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, ...